Blood Flow Devices Market to Hit $1,652.1M by 2032 on Non-Invasive Demand

Burlingame, CA, July 14, 2025 (GLOBE NEWSWIRE) — The global Blood Flow Measurement Devices Market, currently valued at USD 886.0 million in 2025, is projected to grow to USD 1,652.1 million by 2032, registering a CAGR of 9.3% during the forecast period, according to Coherent Market Insights (CMI).

This anticipated growth is primarily fueled by an aging global population, rising cases of cardiovascular disorders, and a strong shift toward minimally invasive surgeries. Technological advancements in Doppler ultrasound systems and laser Doppler flowmeters are improving the precision and reliability of real-time blood flow monitoring, further propelling demand.

Key Market Insights:

Revenue Growth: Market to double from USD 886.0 Mn in 2025 to USD 1,652.1 Mn by 2032.

Top Product Segment: Laser Doppler blood flowmeters projected to generate over USD 314.5 Mn in 2025.

Major Application Area: Cardiovascular disease segment to dominate with 45.5% market share in 2025.

Leading Region: North America to hold over 40% of the market share in 2025.

Emerging Region: Asia Pacific expected to witness significant growth due to rising chronic illness and government support.

Growth Drivers:

The increasing burden of chronic illnesses—notably heart disease, hypertension, and atherosclerosis—is a key factor behind the surge in demand for these devices. They allow for real-time tracking of blood circulation, critical for early diagnosis and intervention. While the market outlook remains strong, the high costs of advanced devices could pose a hurdle to widespread adoption, particularly in low-resource settings.

Overall, the industry is set for robust expansion, with innovations in non-invasive diagnostics and growing global health awareness contributing significantly to market acceleration.